Skip to main content
. 2016 May 13;7(26):39026–39043. doi: 10.18632/oncotarget.9346

Figure 6. HAPLN1 silencing leads to mesenchymal and stem cell marker loss.

Figure 6

Real-time-PCR-assessed mRNA expression of the indicated genes in HepaRG progenitor cells transfected with the indicated siRNAs. HAPLN1 silencing downregulates SNAI1; ACTA2; COL4A1 and LGR5 expression.